| Literature DB >> 23788927 |
Deviprasad Shetty1, Vijayalakshmi Subramaniam, Adarsha Herale, Prema Saldanha, Mahaveer Jain.
Abstract
The most common type of malignancy affecting the upper aerodigestive tract is squamous cell carcinoma. Basaloid squamous cell carcinoma (BSCC) is a rarely seen, high-grade, bimorphic variant of squamous cell carcinoma, which displays distinct histological features. This entity was first described by Wain et al. in 1986. Since then, approximately 170 cases of head and neck basaloid squamous cell carcinoma have been reported. Tonsils are an uncommon site of occurrence of basaloid cell carcinoma. Only 10 cases of basaloid squamous cell carcinoma arising in the tonsils have been described in current English literature. Histopathologically, these carcinomas are characterised by the presence of a basaloid component in close association with squamous cell carcinoma. In this article, a case of BSCC of the tonsil is reported. The clinical and histopathological features of this tumour are discussed. Relevant literature has been reviewed and differential diagnosis of this tumour is discussed.Entities:
Keywords: basaloid squamous cell carcinoma; tonsil
Year: 2012 PMID: 23788927 PMCID: PMC3687447 DOI: 10.5114/wo.2012.31778
Source DB: PubMed Journal: Contemp Oncol (Pozn) ISSN: 1428-2526
Fig. 1Axial contrast enhanced computed tomographic scan showing homogeneously enhancing mass lesion measuring 3.4 × 3 cm in the left tonsillar fossa
Fig. 2Coronal computed tomography image of the oropharynx showing well-defined mass lesion arising from the left tonsillar fossa protruding into the oropharynx
Fig. 3Sagittal reconstruction showing mass arising from tonsillar fossa measuring 3.2 cm craniocaudally, abutting the posterior aspect of the tongue and soft palate
Fig. 4Microphotograph showing lymphoid tissue (tonsillar) with an infiltrating neoplasm composed of masses of basaloid cells with peripheral palisading of cells (HE stain; 100×)
Fig. 5Microphotograph of tumour mass showing a ‘comedo pattern’ with central necrosis in the tumour masses (HE stain; 200×)